The US government just bought $5 million in advanced cancer testing services
What happened
The US government awarded a $5 million contract to Neogenomics Laboratories for specialized cancer testing. This means federal agencies will use advanced genomic and molecular diagnostics for patient care.
Why it matters
This contract shows the US government is investing in advanced diagnostic tools for cancer. It means federal healthcare programs will use more precise testing methods to guide treatment decisions. This could lead to better outcomes for patients covered by these programs.
The signal
Watch for similar contracts in the future, which would indicate a sustained shift towards advanced diagnostics in federal healthcare.